united kingdomen
Investment outlook 2021

Tackling the trilemma

A great year for risky assets
Download the full publication
jeroen-blokland-200x223px.jpg

“The road towards a new normal differs among countries. Those countries managing to solve the trilemma first are also likely to be the economic winners of 2021.”

Jeroen Blokland, Head of Multi Asset

It’s all about the vaccine

  • In our base case, a vaccine becomes available in the first half of 2021. However, of equal importance is the vaccine being sufficiently available, widely distributed and broadly accepted. We see some hiccups and setbacks in the process.

  • Our bull case sees multiple effective vaccines arriving earlier. Logistical challenges in vaccine distribution are dealt with effectively, and the economy is freed from the pendulum swing between lockdowns and re-openings. Here we see room for Keynes’ animal spirits.

  • In our bear case, vaccine development experiences setbacks, with a very limited number of vaccines on the market by only the end of 2021. This does anything but improve the trade-off policymakers have to make between public health, the economy, and personal freedom.

The Executive Summary

Download the summary

Special topics

What 2021 will bring for 5G, the SDGs and Chinese A-shares

Special topics

What 2021 will bring for 5G, the SDGs and Chinese A-shares

Unlocking 5G’s potential
Unlocking 5G’s potential
We believe 2021 will be an inflection point for 5G – and a select group of companies will reap the fruits of this powerful shift.
03-12-2020 | Yearly outlook
The road ahead for the SDGs
The road ahead for the SDGs
The Sustainable Development Goals (SDGs) have been taking sustainable investing to the next level.
Yearly outlook
Filtering out fraud risk in Chinese A-share markets
Filtering out fraud risk in Chinese A-share markets
Chinese equity markets have emerged as one of the big winners following the Covid-19 shock.
26-11-2020 | Yearly outlook
Podcast: A great year for risky assets
Podcast: A great year for risky assets
With several vaccines on the way, 2021 promises to be a great year for equities.
07-12-2020 | Podcast

Leave your details and download the full 2020 investment outlook

This report is not available to users, such as US persons, from countries in which the offering of foreign financial services is not permitted.

Your details will not be shared with third parties. This information is intended exclusively for professional investors. All requests are checked.

Share this page
Logo

Disclaimer

Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.

The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.

In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.

In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.

Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.

If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.

If you do not accept these terms and conditions, as well as the terms of use of the website, please do not continue to use or access any pages on this website.

I Disagree